Fat Loss & Body Composition
Peptides that promote lipolysis, preserve lean mass, and improve body composition without anabolic side effects.
AOD-9604 is the targeted fat-loss peptide — a fragment of HGH that retains its lipolytic properties without the blood sugar and IGF-1 effects of full HGH. For women, cycle-phase timing significantly impacts results.
Peptides in this category (16)
AOD-9604
HGH fragment engineered for fat metabolism without systemic HGH effects.
Evidence Level
Cagrilintide
Long-acting amylin analogue that enhances satiety; often paired with semaglutide (CagriSema) for additive fat loss.
Evidence Level
CJC-1295
Extended GHRH analogue — the perfect stack partner for Ipamorelin.
Evidence Level
Follistatin-344
Myostatin-binding protein researched for muscle growth by removing the body's brake on muscle development.
Evidence Level
GHRP-2
Growth-hormone-releasing peptide that boosts GH and appetite; commonly stacked with a GHRH like CJC-1295.
Evidence Level
GHRP-6
Early-generation GHRP known for a strong hunger signal and GH release — useful for recovery and bulking phases.
Evidence Level
Hexarelin
Potent GHRP with strong GH release and researched cardioprotective effects; used in short cycles.
Evidence Level
IGF-1 LR3
Long-acting insulin-like growth factor analogue researched for muscle hyperplasia and nutrient partitioning.
Evidence Level
MK-677 (Ibutamoren)
Orally active ghrelin-receptor agonist that raises GH and IGF-1 around the clock — no injection required.
Evidence Level
MOTS-c
Mitochondrial-derived peptide that improves insulin sensitivity, metabolic flexibility, and exercise capacity.
Evidence Level
Retatrutide
Next-generation triple agonist (GLP-1 / GIP / glucagon) producing the largest weight-loss results seen in trials to date.
Evidence Level
Semaglutide
The widely studied GLP-1 agonist behind modern weight-loss medicine — strong appetite control and metabolic benefits.
Evidence Level
Sermorelin
Classic GHRH peptide that gently stimulates the body's own growth-hormone release for sleep, recovery, and anti-aging.
Evidence Level
Survodutide
GLP-1 / glucagon dual agonist studied for weight loss and metabolic-associated fatty liver disease (MASH).
Evidence Level
Tesamorelin
GHRH analogue clinically proven to reduce visceral (deep belly) fat and improve body composition.
Evidence Level
Tirzepatide
Dual GLP-1 / GIP agonist for powerful appetite suppression, blood-sugar control, and fat loss.
Evidence Level
14 more peptides in this category
Fasted-state timing protocols, women's cycle-synced guidance, and complete dosing references require a subscription.
Start Free Trial7 days free. Then $24/month.
Explore Other Categories
PepCompass provides educational information only. Nothing on this platform constitutes medical advice. Always consult a licensed healthcare provider before starting any peptide protocol.